Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Replimune Group Inc (REPL)  
$7.04 0.26 (3.56%) as of 4:30 Fri 1/16


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 86,076,000
Market Cap: 605.98(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $2.805 - $14.31
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  861
Guru Rank Value     : 2.2
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Replimune Group is a clinical-stage biotechnology company focused on applying its capabilities in the field of oncolytic immunotherapy to transform the lives of cancer patients through its tumor-directed oncolytic immunotherapies. Co.'s RPx product candidates in its development pipeline include: RP1, which is a selectively replicating version of herpes simplex virus 1 that expresses GALV-GP R(-) and human GM-CSF; RP2, which expresses an anti-CTLA-4 antibody-like protein intended to block the inhibition of the immune response otherwise caused by CTLA-4; and RP3, which expresses immune-activating proteins that stimulate T cells, in addition to anti-CTLA-4 and GALV-GP R(-).

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 25,625 34,779 109,686 255,042
Total Sell Value $257,608 $306,765 $910,419 $2,013,561
Total People Sold 4 5 7 9
Total Sell Transactions 4 5 11 23
End Date 2025-10-19 2025-07-18 2025-01-17 2024-01-18

   
Records found: 208
  Page 1 of 9  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Sarchi Christopher Chief Commercial Officer   •       –      –    2025-12-19 4 A $0.00 $0 D/D 35,000 158,088     -
   Xynos Konstantinos Chief Medical Officer   •       –      –    2025-12-19 4 A $0.00 $0 D/D 60,000 199,685     -
   Patel Sushil Chief Executive Officer   •       •      –    2025-12-19 4 A $0.00 $0 D/D 200,000 533,576     -
   Schwendenman Andrew Chief Accounting Officer   •       –      –    2025-12-19 4 A $0.00 $0 D/D 10,000 78,284     -
   Hill Emily Luisa Chief Financial Officer   •       –      –    2025-12-19 4 A $0.00 $0 D/D 60,000 194,368     -
   Dhingra Kapil Director   –       •      –    2025-12-09 4 S $10.40 $32,958 D/D (3,169) 0 29%     
   Dhingra Kapil Director   –       •      –    2025-12-09 4 OE $1.75 $5,546 D/D 3,169 3,169     -
   Patel Sushil Chief Executive Officer   •       •      –    2025-12-02 4 AS $11.13 $111,300 D/D (10,000) 333,576 -30%     
   Sarchi Christopher Chief Commercial Officer   •       –      –    2025-11-17 4 S $9.10 $47,393 D/D (5,208) 123,088 17%     
   Xynos Konstantinos Chief Medical Officer   •       –      –    2025-11-17 4 S $9.10 $65,957 D/D (7,248) 139,685 17%     
   Hill Emily Luisa Chief Financial Officer   •       –      –    2025-08-15 4 S $5.37 $49,157 D/D (9,154) 134,368 -75%     
   Sarchi Christopher Chief Commercial Officer   •       –      –    2025-05-20 4 S $8.05 $30,179 D/D (3,749) 128,296 53%     
   Astley-Sparke Philip Director   –       •      –    2025-05-20 4 S $8.06 $260,169 D/D (32,279) 1,405,071 53%     
   Patel Sushil Chief Executive Officer   •       •      –    2025-05-20 4 S $8.06 $202,346 D/D (25,105) 343,576 53%     
   Xynos Konstantinos Chief Medical Officer   •       –      –    2025-05-20 4 S $8.06 $64,093 D/D (7,952) 146,933 53%     
   Schwendenman Andrew Chief Accounting Officer   •       –      –    2025-05-20 4 S $8.05 $26,460 D/D (3,287) 68,284 53%     
   Hill Emily Luisa Chief Financial Officer   •       –      –    2025-05-20 4 S $8.05 $20,407 D/D (2,535) 143,522 53%     
   Hill Emily Luisa Chief Financial Officer   •       –      –    2025-04-01 4 A $0.00 $0 D/D 45,000 146,057     -
   Sarchi Christopher Chief Commercial Officer   •       –      –    2025-04-01 4 A $0.00 $0 D/D 45,000 132,045     -
   Xynos Konstantinos Chief Medical Officer   •       –      –    2025-04-01 4 A $0.00 $0 D/D 45,000 154,885     -
   Schwendenman Andrew Chief Accounting Officer   •       –      –    2025-04-01 4 A $0.00 $0 D/D 33,333 71,571     -
   Patel Sushil Chief Executive Officer   •       •      –    2025-04-01 4 A $0.00 $0 D/D 166,667 368,681     -
   Baker Julian   –       •       •   2025-03-05 3 IO $0.00 $0 I/I 0 11,045,336 1%     
   Patel Sushil Chief Executive Officer   •       •      –    2024-12-16 4 AS $12.42 $124,200 D/D (10,000) 202,014 -25%     
   Xynos Konstantinos Chief Medical Officer   •       –      –    2024-11-18 4 S $10.78 $78,112 D/D (7,246) 109,885 22%     
  208 Records found
  1  2  3  4  5  6  7  8  9   
  Page 1 of 9
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2026 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us